If you suspect Mounjaro may be contributing to your symptoms, report this through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
Proven Efficacy and Safety of GLP-1 Therapies The proven efficacy and safety of GLP-1 therapies are also driving the growth of the market
In people who struggle with weight, these signals can be weaker than they should be the body may not produce enough GLP-1, or the brain may not respond to it with the same sensitivity
The changes are, however, made in light of the recent market challenges Novo Nordisk has been facing, and the development of the companys share price since mid-2024, the company said in a statement
Huberman regularly incorporates is sauna use combined with cold exposure, both of which have been linked to potential benefits for cellular resilience and recovery